Fukoku Mutual Life Insurance CO Catalent, Inc. Transaction History

Fukoku Mutual Life Insurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$72.36 - $113.1 $32,562 - $50,895	-450 Reduced 13.72%	2,830 $205,000
Q2 2022 Jul 29, 2022	BUY	$87.2 - $114.05 $52,320 - $68,430	600 Added 22.39%	3,280 $352,000
Q4 2021 Jan 25, 2022	BUY	$119.57 - $139.07 $11,957 - $13,907	100 Added 3.88%	2,680 $343,000
Q3 2021 Nov 09, 2021	BUY	$109.17 - $142.35 $52,401 - $68,328	480 Added 22.86%	2,580 $343,000
Q4 2020 Jan 27, 2021	BUY	$85.88 - $105.36 $180,348 - $221,256	2,100 New	2,100 $219,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.